Detalhe da pesquisa
1.
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
Lancet
; 403(10435): 1460-1471, 2024 Apr 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38554725
2.
Safety and efficacy of percutaneous image-guided ablation for soft tissue sarcoma metastases to the liver.
Cancer
; 2024 Apr 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38642369
3.
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial.
Lancet Oncol
; 23(9): 1156-1166, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35934010
4.
Outcomes of systemic therapy in metastatic phyllodes tumor of the breast.
Breast Cancer Res Treat
; 186(3): 871-882, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33575859
5.
Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma.
Cancer
; 126(1): 105-111, 2020 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31509242
6.
Synovial Sarcoma: A Complex Disease with Multifaceted Signaling and Epigenetic Landscapes.
Curr Oncol Rep
; 22(12): 124, 2020 10 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33025259
7.
Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy.
Ann Surg Oncol
; 24(8): 2145-2154, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28397189
8.
Periosteal mesenchymal chondrosarcoma of the tibia with multifocal bone metastases: a case report.
Skeletal Radiol
; 46(7): 995-1000, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28352960
9.
The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study.
J Card Fail
; 22(6): 433-8, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27079675
10.
Prognosis of T1 synovial sarcoma depends upon surgery by oncologic surgeons.
J Surg Oncol
; 114(4): 490-4, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27220538
11.
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration study.
Cancer
; 120(16): 2448-56, 2014 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24797726
12.
Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors.
Ann Surg Oncol
; 21(8): 2499-505, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24639192
13.
SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection.
Int J Radiat Oncol Biol Phys
; 118(4): 971-978, 2024 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37914142
14.
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors.
Cancers (Basel)
; 16(9)2024 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38730662
15.
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience.
Cancers (Basel)
; 16(9)2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38730715
16.
Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).
Cancer
; 119(8): 1555-61, 2013 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23335221
17.
Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model.
Mod Pathol
; 25(9): 1298-306, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22575866
18.
Erratum to: Periosteal mesenchymal chondrosarcoma of the tibia with multifocal bone metastases: a case report.
Skeletal Radiol
; 46(7): 1001, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28389822
19.
Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions.
Adv Radiat Oncol
; 7(3): 100913, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35647398
20.
Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma.
Nat Commun
; 13(1): 5296, 2022 09 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36075914